Annual Total Liabilities
$6.13 M
+$1.21 M+24.65%
December 31, 2023
Summary
- As of March 10, 2025, CNSP annual total liabilities is $6.13 million, with the most recent change of +$1.21 million (+24.65%) on December 31, 2023.
- During the last 3 years, CNSP annual total liabilities has risen by +$4.23 million (+221.87%).
- CNSP annual total liabilities is now at all-time high.
Performance
CNSP Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$4.06 M
-$2.71 M-40.01%
September 30, 2024
Summary
- As of March 10, 2025, CNSP quarterly total liabilities is $4.06 million, with the most recent change of -$2.71 million (-40.01%) on September 30, 2024.
- Over the past year, CNSP quarterly total liabilities has dropped by -$2.08 million (-33.85%).
- CNSP quarterly total liabilities is now -40.01% below its all-time high of $6.76 million, reached on June 30, 2024.
Performance
CNSP Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
CNSP Total Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +24.6% | -33.9% |
3 y3 years | +221.9% | +68.5% |
5 y5 years | +397.6% | +68.5% |
CNSP Total Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +136.4% | -40.0% | +339.1% |
5 y | 5-year | at high | +1872.0% | -40.0% | +1453.2% |
alltime | all time | at high | +2678.9% | -40.0% | +1453.2% |
CNS Pharmaceuticals Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $4.06 M(-40.0%) |
Jun 2024 | - | $6.76 M(+11.0%) |
Mar 2024 | - | $6.09 M(-0.7%) |
Dec 2023 | $6.13 M(+24.6%) | $6.13 M(+50.7%) |
Sep 2023 | - | $4.07 M(+1.8%) |
Jun 2023 | - | $4.00 M(+1.9%) |
Mar 2023 | - | $3.92 M(-20.3%) |
Dec 2022 | $4.92 M(+89.7%) | $4.92 M(+295.4%) |
Sep 2022 | - | $1.24 M(+34.7%) |
Jun 2022 | - | $923.90 K(-13.6%) |
Mar 2022 | - | $1.07 M(-58.8%) |
Dec 2021 | $2.59 M | $2.59 M(+7.8%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2021 | - | $2.41 M(+31.5%) |
Jun 2021 | - | $1.83 M(-3.7%) |
Mar 2021 | - | $1.90 M(-0.2%) |
Dec 2020 | $1.91 M(+512.7%) | $1.91 M(+273.0%) |
Sep 2020 | - | $510.80 K(+95.6%) |
Jun 2020 | - | $261.20 K(-22.3%) |
Mar 2020 | - | $336.00 K(+8.0%) |
Dec 2019 | $311.00 K(-74.8%) | $311.00 K(-77.7%) |
Sep 2019 | - | $1.40 M(+10.6%) |
Jun 2019 | - | $1.26 M(+2.6%) |
Dec 2018 | $1.23 M(+458.5%) | $1.23 M |
Dec 2017 | $220.70 K | - |
FAQ
- What is CNS Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals annual total liabilities year-on-year change?
- What is CNS Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals quarterly total liabilities year-on-year change?
What is CNS Pharmaceuticals annual total liabilities?
The current annual total liabilities of CNSP is $6.13 M
What is the all time high annual total liabilities for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high annual total liabilities is $6.13 M
What is CNS Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, CNSP annual total liabilities has changed by +$1.21 M (+24.65%)
What is CNS Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of CNSP is $4.06 M
What is the all time high quarterly total liabilities for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high quarterly total liabilities is $6.76 M
What is CNS Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, CNSP quarterly total liabilities has changed by -$2.08 M (-33.85%)